Share

Canagliflozin Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

Canagliflozin improves renal outcomes in people with type 2 diabetes mellitus (T2DM) with or at high risk for cardiovascular (CV) disease, according to data recently presented at the 2018 National Kidney Foundation’s Spring Clinical Meetings in Austin, Texas.. This benefit was observed in people with both preserved and reduced kidney function, as measured by estimated...
Share

Moving Targets: Immunotherapy & Endocrinopathies

EN0418_cover Immune checkpoint inhibitors unleash the immune system on cancer to great effect and increasing survival rates. However, but switched-on immune cells set their sights on other targets, many times the endocrine system. Immunotherapy has boosted survival rates for some of the most recalcitrant forms of cancer with an approach that is revolutionizing the field. But...
Share

Researchers Suggest Possible Biomarker for Diabetic Cardiomyopathy

Alterations in the myocardial ghrelin-GHSR1a system may predict diabetic cardiomyopathy (DCM), according to a study recently published in the Journal of the Endocrine Society. Researchers led by Savita Dhanvantari, PhD, of the Lawson Health Research Institute in London, Ontario point out that DCM is characterized by progressive cardiac dysfunction, and that the early stages of...
Share

New Study Links PCOS to Mental Health Disorders

Women with polycystic ovary syndrome (PCOS), the most common hormone condition among young women, are prone to mental health disorders, and their children face an increased risk of developing attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), according to a new study published in the The Journal of Clinical Endocrinology & Metabolism. PCOS affects...
Share

ENDO 2018: Insulin Pump Known to Be Effective in Adolescents, Adults Also Benefits Children

The MiniMed™ 670G insulin pump system (Medtronic, Northridge, California) can improve glycemic outcomes in children with type 1 diabetes as young as seven years of age, according to an industry-funded study. The results were presented  at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill. “The MiniMed™ 670G system can effectively...

As much as we know today about the endocrine system and the effects it has on the body, there remains so much that we do not know. Discoveries are made every day, and our understanding of the endocrine system is always growing and changing. Serving patients to the best of an endocrinologist’s abilities means being aware of all the latest developments in endocrine research. This includes the newest and most complete information concerning such endocrinology research topics as new treatments and new methods for disease prevention. Identifying symptoms and making the connections between those symptoms and endocrine disease can lead to greater understanding and ultimately better treatment for patients. More advanced prevention techniques can help patients stave off disease before it can impact their lives. Having the most current information can make a tremendous difference in the quality of life for your patients.

This section features some of the most current and forward-looking articles concerning the latest research in endocrinology. Written by and for endocrinologists, these articles are provided to keep you up to date with the most relevant developments in the field of endocrinology. You can access the information you need about new technology, new treatments and general information to help you serve your patients with better overall care. Our understanding of the endocrine system is always evolving. With Endocrine News, you can ensure that your knowledge of the field won’t be left behind. What’s more, your patients will always have access to the most advanced information out there.